Vaccitech Announces Data Presentations at AASLD’s Liver Meeting® 2021

NEXT STORY
Athenex and the Center for Cell and Gene Therapy Announce Allowance of Our First U.S. Patent Claims Around CAR-NKT Cell Therapy
PREV STORY
Adamis Receives FDA Approval for ZIMHI
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Molecular Partners Reports Continued Progress of Ensovibep Global Clinical Program; Positive in vitro Data Demonstrating Maintained Inhibition of Delta and All Other Known Variants of Concern of SARS-CoV-2

author_avatar
NASDAQ Market News

Surface Oncology to Present at the Baird 2019 Global Healthcare Conference

author_avatar
NASDAQ Market News

FIT Biotech Oy: Tekes issues a partial decision on the company’s rectification request related to Tekes’s claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

FIT BIOTECH OYCompany releaseSeptember 23, 2016 at 16:40 EET        Tekes issues a partial ...

author_avatar
NASDAQ Market News